Analysts expect CytomX Therapeutics, Inc. to report revenue of 9.71 M for Q3 26, against a range of 9.03 M to 10.39 M. The most recent reported quarter, Q2 26, came in at 1.42 M, a 89.2% miss against the 13.15 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 33.43 M | 38.09 M | 50.92 M | 18.66 M | 5.96 M | 661,000.00 | 10.26 M | 1.42 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 17.74 M | 13.01 M | 40.69 M | 19.59 M | 12.64 M | 7.72 M | 5.47 M | 14.14 M | 10.39 M | 6.05 M | 5.58 M | 5.30 M | 16.53 M | 10.29 M | 8.50 M | 3.91 M | ||||||||||
| Low Estimate | 15.34 M | 11.89 M | 34.04 M | 16.50 M | 11.27 M | 6.53 M | 4.49 M | 12.15 M | 9.03 M | 4.99 M | 4.65 M | 4.80 M | 15.08 M | 9.38 M | 7.07 M | 3.49 M | ||||||||||
| Consensus Estimate | 16.54 M | 12.45 M | 37.36 M | 18.05 M | 11.96 M | 7.12 M | 4.98 M | 13.15 M | 9.71 M | 5.52 M | 5.12 M | 5.05 M | 15.80 M | 9.83 M | 7.78 M | 3.70 M |
Analysts expect CytomX Therapeutics, Inc. to report earnings per share of -0.07 for Q3 26, against a range of -0.07 to -0.07. The most recent reported quarter, Q2 26, came in at -0.09, a 28.6% miss against the -0.07 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.07 | 0.22 | 0.27 | 0.00 | -0.09 | -0.17 | -0.10 | -0.09 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.16 | -0.20 | 0.11 | -0.05 | -0.05 | -0.09 | -0.12 | -0.06 | -0.07 | -0.10 | -0.11 | -0.11 | -0.13 | -0.14 | -0.09 | -0.13 | ||||||||||
| Low Estimate | -0.18 | -0.22 | 0.11 | -0.07 | -0.05 | -0.11 | -0.14 | -0.08 | -0.07 | -0.12 | -0.11 | -0.11 | -0.15 | -0.16 | -0.11 | -0.15 | ||||||||||
| Consensus Estimate | -0.17 | -0.21 | 0.11 | -0.06 | -0.05 | -0.10 | -0.13 | -0.07 | -0.07 | -0.11 | -0.11 | -0.11 | -0.14 | -0.15 | -0.10 | -0.14 |
Pull Wall Street consensus for CytomX Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=CTMX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "CTMX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=CTMX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();